Neuropharmacology Flashcards
Which of the following has an active metabolite? A. Clonazepam B. Carbamazepine C. Phenobarbital D. Lorazepam
Carbamazepine
Which of the following anti-epileptic drugs is significantly excreted unchanged in the urine? A. Ethosuximide B. Phenytoin C. Carbamazepine D. Diazepam
Ethosuximide
A patient with hepatic failure develops several episodes of generalized seizures. Based on pharmacokinetics, which of the following would best be suited for this patient? A. Ethosuximide B. Valproic acid C. Topiramate D. Carbamazepine
Topiramate
Which of the following anti-epileptic drugs auto-induces its own metabolism after several weeks of use? A. Phenytoin B. Lamotrigine C. Topiramate D. Gabapentin
Lamotrigine
Which of the following has dose dependent oral bioavailability? A. Lamotrigine B. Topiramate C. Ethosuximide D. Gabapentin
Gabapentin
Drugs used in the treatment of Parkinsons disease are primarily mediated by which of the following dopamine receptors? A. D1 B. D2 C. D3 D. D4
D2
Which of the following conditions would respond to treatment with metoprolol? A. Physiologic tremor B. Essential tremor C. Tourettes syndrome D. Wilsons disease
Essential tremor
Which of the following is used to prevent the peripheral conversion of levodopa to dopamine increasing its bioavailability? A. Levodopa B. Carbidopa C. Pramipexole D. Bromocriptine
Carbidopa
Which of the following drugs used for the treatment of Parkinsons disease is a selective, reversible, peripherally acting COMT inhibitor? A. Tolcapone B. Entacapone C. Selegiline D. Pramipexole
Entacapone
Which of the following drugs used in the treatment of Parkinsons disease is a non-ergot dopamine agonist with the same efficacy as bromocriptine? A. Tolcapone B. Carbidopa C. Pergolide D. Ropirinole
Ropirinole
Which of the following is used to prevent the peripheral conversion of levodopa to dopamine increasing its bioavailability? A. Levodopa B. Benzserazide C. Pramipexole D. Bromocriptine
Benzserazide
Which of the following drugs used for the treatment of Parkinsons disease is a selective, reversible, peripherally and centrally acting COMT inhibitor? A. Tolcapone B. Entacapone C. Selegiline D. Pramipexole
Tolcapone
Which of the following antiepileptic drugs follows zero order kinetics within its therapeutic range? A. Vigabatrin B. Lamotrigine C. Valproic acid D. Phenytoin
Phenytoin
Which of the following drugs would increase the half life of levodopa?
a. carbidopa
b. benzeraside
c. entacapone
d. all of the above
all of the above
Which of the following anti-epileptic drug has the least protein binding? A. Lamotrigine B. Phenytoin C. Topiramate D. Gabapentin
Gabapentin
Which of the following anti-epileptic drugs is significantly excreted unchanged in the urine? A. Phenytoin B. Levetiracetam C. Lorazepam D. Diazepam
Levetiracetam
A patient with renal failure develops several episodes of generalized seizures. Based on pharmacokinetics, which of the following would best be suited for this patient? A. Topiramate B. Valproic acid C. Phenobarbital D. Gabapentin
Valproic acid
In case of overdose, alkalinization of urine increases excretion of unchanged drug in which of the following antiepileptic drugs? A. Clonazepam B. Carbamazepine C. Phenobarbital D. Lorazepam
Phenobarbital
What is the mode of action of LEVETIRACETAM?
- does not share with other antiepileptic drugs any of their three main mechanisms, such as sodium channel blockade, inhibition of calcium currents, or increase in GABAergic inhibitory responses
- can oppose the activity of negative modulators
of GABA- and glycine-gated currents, and can partially inhibit N-type calcium currents - Binds to synaptic vesicle protein SV2A, which is involved in synaptic vesicle exocytosis
What is the mode of action of PERAMPANEL?
blocks the action of glutamate at AMPA receptors
What is the mode of action of LACOSAMIDE?
- enhancing slow inactivation of voltage-gated Na channels resulting in stabilization of hyperexcitable neuronal membranes
- Binds to collapsing response mediator protein-2 (CRMP-2), a phosphoprotein which is primarily expressed in the nervous system and is involved in neuronal differentiation and control of axonal outgrowth – suggested to mediate a putative neuroprotective effect and to prevent neurodegenerative
What is the mode of action of VIGABATRIN?
- GABA analog
- Binds irreversibly & covalently to GABA-transaminase causing permanent inactivation
- Inactivation of GABA-transaminase (which is responsible for the breakdown of GABA in neurons & glia, results in an increase in brain (synaptic) GABA)
Treatment of Parkinsons disease with dopaminergic agents may potentially cause hallucinations due to the effects of these drugs on which of the following pathways? A. Spinothalamic B. Mesolimbic and mesocortical C. Nigrostriatal D. Tuberohypophyseal
Mesolimbic and mesocortical
Which of the following drugs used in the treatment of Parkinsons disease is a non-ergot dopamine agonist with the same efficacy as bromocriptine? A. Tolcapone B. Carbidopa C. Pergolide D. Pramipexole
Pramipexole
A patient with liver disease also has parkinsons disease. Which of the following dopamine agonists would probably be the safest to use?
a. pergolide
b. pramipexole
c. bromocriptine
d. ropinirole
Pramipexole
Which of the following is a COMT inhibitor, can increase and prolonged the bioavailability of exogenously administered levodopa but has been reported to cause fulminant liver failure?
a. Rasagiline
b. Selegiline
c. Entacapone
d. Tolcapone
Tolcapone
Which of the following drugs can be used for the treatment of Huntingtons disease and Tourettes syndrome?
a. Haloperidol
b. Reserpine
c. Clonidine
d. Benztropine
Haloperidol
Which of the following is an anti-viral agent that has been proven to be effective in the treatment of Parkinsons disease?
a. bromocriptine
b. pramipexole
c. pergolide
d. amantadine
amantadine
The following are advantages of dopamine agonists used for Parkinsons disease EXCEPT:
a. requires enzymatic conversion
b. no potentially toxic metabolites
c. dopamine agonists can be stored and released by degenerating neurons
d. substances with highly specific actions on receptor subtypes can be used or developed
requires enzymatic conversion
Which of the following drug used for parkinsons disease is given subcutaneously for temporary relief of off-periods of akinesia?
a. bromocriptine
b. pramipexole
c. apomorphine
d. amantadine
apomorphine
What is the mechanism of action of zonisamide?
A. enhances potassium channel opening
B. blocks GABA reuptake
C. inhibits GABA transaminase
D. blocks ligand gated calcium channels
E. blocks high frequency firing of voltage gated sodium channels
- activity-dependent Na channels blocker (partial)
- T-type Ca channels blocker
- Inhibition of K-mediated glutamate release
- Increase in extracellular levels of dopamine and serotonin
- Up-regulation of excitatory amino-acid carrier-1 (EAAC-1)
- Down-regulation of the expression of GABA transporter-1 (GAT-1)
- low potency carbonic anhydrase inhibition
What is the enzyme that catalyzes the rate limiting step for the synthesis of dopamine?
tyrosine hydroxylase
converts tyrosine to dopamine
Levodopa’s absorption in the gut is greatest in the __________
proximal small intestine
Mode of action of CARBAMAZEPINE 4
1 Acts as a use-dependent blocker of voltage-sensitive Na-channels
2 Inhibits L-type Ca channels
3 Inhibits release of glutamate
4 moderate anticholinergic action
Mode of action of CLOBAZAM 3
just like CLONAZEPAM
- Binds to benzodiazepine receptors at the GABA-A ligand-gated chloride channel complex
- Enhances the inhibitory effects of GABA
- Boosts Cl conductance through GABA-regulated channels
Mode of action of CLONAZEPAM 3
just like CLOZAPAM
- Binds to benzodiazepine receptors at the GABAA ligand-gated chloride channel complex
- Enhances the inhibitory effects of GABA
- Boosts chloride conductance through GABA-regulated channels
Mode of action of LAMOTRIGINE 2
- use-dependent blocker of v-sensitive Na channels
- Inhibits release of glutamate
Mode of OXCARBAZEPINE 4
1 use-dependent blocker of v-sensitive Na channels
2 Increases K conductance
3 Modulates high-v activated Ca channels
4 reduces glutamate release
Mode of PHENOBARBITAL
1 GABA inhibition enhancement : Enhances postsynaptic GABAA receptor-mediated Cl currents by prolonging the opening of the chloride ionophore
2 reduction of Ca-dependent action potentials
Mode of action of PHENYTOIN 3
1 use-dependent blocker of v-sensitive Na channels
2 Regulates calmodulin and second messenger systems
3 Inhibits Ca channels and Ca sequestration
Mode of action of PREGABALIN 1
1 closes N and P/Q presynaptic Ca-channels bybinding to the α2-δ subunit of v-gated Ca-channels
- Although structurally related to GABA, it does not directly act on GABA or its receptors
Mode of action of VALPROATE 4
1 GABA: increases GABA by inhibition of GABAtransaminase, succinic semialdehyde dehydrogenase, or through an increase in glutamic acid decarboxylase
2 Na and K: Can reduce sustained repetitive high-frequency firing by blocking v-sensitive Na channels or by activating Ca-dependent K conductance
3 aspartate: Decreases brain levels of the excitatory amino acid aspartate
4 glutamate: Decreases the expression of hippocampal glutamate transporter-1
None of the identified actions are widely accepted as the predominant relevant mechanism
Mode of action of TOPIRAMATE (6)
1 GABA: Enhances GABA-mediated inhibition
2 Na: Inhibits v-dependent Na channels
3 K: Enhances K channel conduction
4 Ca: Inhibition of L-type high v-activated Ca channels
5 Glutamate: Decreases glutamate-mediated excitatory neurotransmission
6 Carbonic anhydrase: Low potency inhibition
7 Inhibits AMPA receptors
Anti-Epileptic Drugs that act PRIMARILY on Na Channels?
Other AEDs that may also act on Na channels?
Phenytoin
Carbamazepine
Oxcarbazepine
Lamotrigine
other drugs: Valproate, Zonisamide, Gabapentin, Felbamate, Topiramate
Anti-Epileptic Drugs that act PRIMARILY on Ca Channels?
Other AEDs that may also act on Ca channels?
Ethosuximide
other drugs: Phenytoin, Valproate, Phenobarbital, Lamotrigine, Carbamazepine, Oxcarbazepine, Zonisamide, Gabapentin, Felbamate, Topiramate, ?Levetiracetam